Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 496 AL 510

Intensive cycle ergometer training improves gait speed and endurance in patients with Parkinson's disease: A comparison with treadmill training

Arcolin I, Pisano F, Delconte C, Godi M, Schieppati M, Mezzani A, Picco D, Grasso M, Nardone A.

Restor Neurol Neurosci. 2016;34(1):125-38. doi: 10.3233/RNN-150506.

Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease

Greig SL, McKeage K.

CNS Drugs. 2016 Jan;30(1):79-90. doi: 10.1007/s40263-015-0306-3.

Comparison of strategies for non-perturbing labeling of α-synuclein to study amyloidogenesis

Haney CM, Wissner RF, Warner JB, Wang YJ, Ferrie JJ, J Covell D, Karpowicz RJ, Lee VM, Petersson EJ.

Org Biomol Chem. 2016 Feb 7;14(5):1584-92. doi: 10.1039/c5ob02329g.

Early-Life Toxic Insults and Onset of Sporadic Neurodegenerative Diseases-an Overview of Experimental Studies

Tartaglione AM, Venerosi A, Calamandrei G.

Curr Top Behav Neurosci. 2016;29:231-264. doi: 10.1007/7854_2015_416.

Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson's Disease

Segura-Aguilar J, Muñoz P, Paris I.

Curr Med Chem. 2016;23(4):346-59. doi: 10.2174/0929867323666151223094103.

Compensatory neural mechanisms in cognitively unimpaired Parkinson disease

Poston KL, YorkWilliams S, Zhang K, Cai W, Everling D, Tayim FM, Llanes S, Menon V.

Ann Neurol. 2016 Mar;79(3):448-63. doi: 10.1002/ana.24585. Epub 2016 Feb 10.

Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators

Bastias-Candia S, Garrido A N, Zolezzi JM, Inestrosa NC.

Curr Pharm Des. 2016;22(10):1312-23. doi: 10.2174/1381612822666151223103038.

Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome

Bilo L, Peluso S, Antenora A, De Rosa A, Esposito M, Barbato S, Pappatà S, De Michele G.

Int J Neurosci. 2016 Dec;126(12):1136-8. doi: 10.3109/00207454.2015.1135438. Epub 2016 Jan 25.

Optimizing microdialysis for deep brain stimulation

Lopez WO, Fonoff ET, Hamani C, Tierney TS, Alho E, Ghilardi MG, Teixeira MJ, Martinez RC.

Front Biosci (Elite Ed). 2016 Jan 1;8(2):299-310. doi: 10.2741/E768.

Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data

François C, Hauser RA, Aballéa S, Dorey J, Kharitonova E, Hewitt LA.

J Med Econ. 2016;19(5):515-25. doi: 10.3111/13696998.2015.1136827. Epub 2016 Jan 18.

The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases

Majumder K, Mine Y, Wu J.

J Sci Food Agric. 2016 May;96(7):2303-11. doi: 10.1002/jsfa.7600. Epub 2016 Feb 18.

Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke

Llull L, Amaro S, Chamorro Á.

Curr Neurol Neurosci Rep. 2016 Jan;16(1):4. doi: 10.1007/s11910-015-0604-7.

Advances in Biomarker Research in Parkinson's Disease

Mehta SH, Adler CH.

Curr Neurol Neurosci Rep. 2016 Jan;16(1):7. doi: 10.1007/s11910-015-0607-4.

Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer

Marks WJ Jr, Baumann TL, Bartus RT.

Hum Gene Ther. 2016 Jul;27(7):522-7. doi: 10.1089/hum.2015.134. Epub 2016 Feb 24.

Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease

Gunay MS, Ozer AY, Chalon S.

Curr Neuropharmacol. 2016;14(4):376-91. doi: 10.2174/1570159x14666151230124904.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias